Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Insufficiency
Primary Adrenal Insufficiency
▪ Sex:
– Addison disease is more common in girls.
Adrenoleukodystrophy:
– Inherited disorders of impaired peroxisomal degradation of very-long-chain fatty
acids, resulting in adrenal insufficiency and progressive neurologic deterioration
ACTH unresponsiveness:
– Inherited defect in the ACTH receptor, resulting in isolated glucocorticoid deficiency
with hypoglycemia in infancy and hyperpigmentation
PATHOPHYSIOLOGY
Adrenal hypoplasia congenita:
A defect in adrenal organogenesis
CAH:
A group of enzymatic disorders of steroid metabolism, of which 21-
hydroxylase deficiency is the most common
Waterhouse-Friderichsen syndrome:
Bilateral adrenal gland hemorrhage classically associated with fulminant
meningococcemia, but also reported with Staphylococcus aureus and
Streptococcus pneumoniae
DIAGNOSIS
HISTORY
The symptoms of primary adrenal insufficiency are nonspecific and similar to those
found in many disease processes. The electrolyte picture of adrenal insufficiency can
be seen in renal disorders, obstructive uropathy, and isolated aldosterone deficiency:
PHYSICAL EXAM
Hyperpigmentation, especially on lip borders, buccal mucosa, nipples,
and over skin creases
Weight loss
Hypotension
Evaluate for other signs of autoimmune disease (e.g., thyromegaly,
vitiligo).
Pubertal staging
Signs of virilization in females
DIAGNOSTIC TESTS
Specific:
Cosyntropin (Cortrosyn) stimulation test:
Administer cosyntropin (synthetic ACTH) 250 mcg IV and measure cortisol at 30 and 60
minutes. An insufficient cortisol response is diagnostic of adrenal insufficiency
Nonspecific:
Electrolytes:
◦ Hyponatremia: Result of the mineralocorticoid defect and glucocorticoid deficiency;
combination sodium loss from kidneys, and the inability to excrete a water load
◦ Hyperkalemia and acidosis: Chronic mineralocorticoid deficiency with the inability to
excrete potassium and acid
◦ Hypercalcemia: Most likely a result of increased calcium absorption due to the lack of
glucocorticoid effect on the gut
◦ Hypoglycemia: Glucocorticoids have permissive effects on gluconeogenesis.
◦ Renin levels are elevated when a mineralocorticoid deficiency is present.
DIFFERENTIAL DIAGNOSIS
Autoimmune adrenal cortical destruction
Infectious adrenal cortical destruction:
– Tuberculous
– Fungal
– HIV
Adrenal hemorrhage
Neoplastic adrenal infiltration
Adrenoleukodystrophy
ACTH unresponsiveness
Adrenal hypoplasia congenita
TREATMENT
Acute adrenal insufficiency
• A blood sample should be obtained before therapy to determine
electrolytes, glucose, ACTH, cortisol, aldosterone, and plasma renin
activity.
• Intravenous solution of 5% glucose in 0.9% saline should be
administered to correct hypoglycemia, hypovolemia, and hyponatremia.
• Hypotonic fluids (e.g., 5% glucose in water or 0.2% saline) must be
avoided because they can precipitate or exacerbate hyponatremia.
TREATMENT
Correct hyperkalemia:
Calcium:
Calcium gluconate 100 mg/kg/dose IV of 10% solution over 3–5 min
Insulin and glucose:
Insulin 0.1 units/kg IV over 30 min
Dextrose 0.5 g/kg IV over 30 min
Sodium bicarbonate:
1–2 mEq/kg IV
TREATMENT
Hydrocortisone
Given intravenously. As much as
• 10 mg for infants
• 25 mg for toddlers
• 50 mg for older children
• 100 mg for adolescents
should be administered as a bolus .
A similar total amount given in divided doses at 6 hr intervals for the 1st 24
hr. These doses may be reduced during the next 24 hr if progress is
satisfactory.
TREATMENT
chronic replacement therapy
Hydrocortisone
orally in daily doses of 10 mg/m2/24 hr in 3 divided doses;
some patients require 15 mg/m2/24 hr to minimize fatigue, especially in the morning
During situations of stress, such as periods of infection or minor operative procedures,
the dose of hydrocortisone should be increased 2-3–fold.
Fludrocortisone
a synthetic mineralocorticoid is given orally in doses of 0.05-0.2 mg daily.
Patient Monitoring
• Clinical status
• Reduction in hyperpigmentation
• Electrolytes, ACTH, and renin levels
• Screen for polyautoimmune disorders.
• Growth
• Very-long-chain fatty acid levels and neurologic function in
adrenoleukodystrophy
• Pubertal development
Thank
you